Clinical trial
Assessing Clinical Outcomes in Alzheimer's Disease Agitation
NCT04797715
Study timeline
Study start (actual)2020-12-31Date precision: day
Registry last updated2023-11-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Agitation,Psychomotorunresolved
Interventions
Sponsors & collaborators
Axsome Therapeutics, Inc.lead sponsor
Mapped research locations
MiamiFlorida, United States3OrlandoFlorida, United States2New YorkNew York, United States1HoustonTexas, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1San AntonioTexas, United States1San DiegoCalifornia, United States1TampaFlorida, United States1AustinTexas, United States1Las VegasNevada, United States1CharlotteNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04797715 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.